Home › Funds › Morgan Stanley › MDGL
Morgan Stanley position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)139.01K sh
Reported value held$74.64M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 68.17K | $5.44M | New |
| Q4 2021 | 48.34K | $4.10M | Reduce |
| Q1 2022 | 98.02K | $9.62M | Add |
| Q2 2022 | 82.95K | $5.94M | Reduce |
| Q3 2022 | 59.06K | $3.84M | Reduce |
| Q4 2022 | 109.42K | $31.76M | Add |
| Q1 2023 | 147.78K | $35.80M | Add |
| Q2 2023 | 74.29K | $17.16M | Reduce |
| Q3 2023 | 171.77K | $25.09M | Add |
| Q4 2023 | 151.92K | $35.15M | Reduce |
| Q1 2024 | 288.61K | $77.07M | Add |
| Q2 2024 | 220.03K | $61.64M | Reduce |
| Q3 2024 | 269.39K | $57.17M | Add |
| Q4 2024 | 218.48K | $67.42M | Reduce |
| Q1 2025 | 384.83K | $127.47M | Add |
| Q2 2025 | 247.96K | $75.04M | Reduce |
| Q3 2025 | 249.65K | $114.50M | Add |
| Q4 2025 | 150.46K | $87.62M | Reduce |
| Q1 2026 | 191.29K | $100.14M | Add |
| Q2 2026 | 139.01K | $74.64M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MDGL
- Vanguard Group 1.81M sh · $1.05B · Q4 2025
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- BlackRock Inc 1.20M sh · $644.75M · Q2 2026
- Wellington Management Group 825.71K sh · $443.37M · Q2 2026
- Citadel Advisors 688.13K sh · $369.49M · Q2 2026
- UBS Group AG 401.71K sh · $215.70M · Q2 2026
- Geode Capital Management 374.88K sh · $201.34M · Q2 2026
- Fidelity Management & Research (FMR) 356.20K sh · $191.26M · Q2 2026
- Invesco Ltd 301.44K sh · $161.86M · Q2 2026
- Goldman Sachs Group 246.28K sh · $132.24M · Q2 2026
- Norges Bank Investment Management 213.89K sh · $114.85M · Q2 2026